Get the Stockscreener App
6.90
0.00%
0.00
After Hours:
6.90
Accolade Inc Stock (ACCD) Latest News
Acclade CEO Rajeev Singh sells shares worth $8,103 - MSN
AcColade CFO Barnes sells shares worth $1,056 - MSN
Fairman Group LLC Has $6.16 Million Stake in Accolade, Inc. (NASDAQ:ACCD) - MarketBeat
Accolade, Inc. (NASDAQ:ACCD) Sees Significant Decline in Short Interest - MarketBeat
Accolade president Robert Cavanaugh sells $1,735 in stock - MSN
Sumitomo Mitsui Trust Group Inc. Decreases Holdings in Accolade, Inc. (NASDAQ:ACCD) - MarketBeat
Accolade (NASDAQ:ACCD) Given "Equal Weight" Rating at Stephens - MarketBeat
Accolade CEO Rajeev Singh sells $3,504 in stock - MSN
Accolade CFO Barnes sells shares worth $1,521 By Investing.com - Investing.com Nigeria
$TOCKHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger – ENFN, VCSA, ACCD, AVAV - GlobeNewswire Inc.
Accolade CFO Barnes sells shares worth $1,521 - MSN
Accolade president Robert Cavanaugh sells $1,735 in stock By Investing.com - Investing.com Nigeria
Accolade CEO Rajeev Singh sells $3,504 in stock By Investing.com - Investing.com Australia
Brokerages Set Accolade, Inc. (NASDAQ:ACCD) PT at $7.55 - MarketBeat
$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The MergerKAVL, VCSA, ACCD, AVAV - The Malaysian Reserve
Accolade president Robert Cavanaugh sells shares worth $3,857 By Investing.com - Investing.com Australia
Accolade president Robert Cavanaugh sells shares worth $3,857 - MSN
Accolade's EVP Richard Eskew sells $2,701 in stock - Investing.com India
Accolade's EVP Richard Eskew sells $2,701 in stock By Investing.com - Investing.com South Africa
Accolade Expands Virtual Care to Medicare Beneficiaries Nationwide Through PlushCare Direct-to-Consumer Offering - PR Newswire
Accolade, Inc. (NASDAQ:ACCD) Short Interest Up 10.3% in January - MarketBeat
Accolade Sports Collection Review: A Retro Trip with Clunky Gameplay - imdb
Nisa Investment Advisors LLC Raises Holdings in Accolade, Inc. (NASDAQ:ACCD) - MarketBeat
Why Accolade Inc (ACCD) Is Skyrocketing So Far In 2025 - Insider Monkey
Cathie Wood's ARK ETF Buys CRISPR, Sells Roblox and Accolade Stock - MSN
Financial Analysis: Smart Powerr (NASDAQ:CREG) and Accolade (NASDAQ:ACCD) - Defense World
Cathie Wood's Ark Invest Bets On Biotech With CRISPR Therapeutics Investment, Exits Roblox - Benzinga India
Accolade, Inc. (NASDAQ:ACCD) Short Interest Update - Defense World
Cathie Wood’s ARK ETF Buys CRISPR, Sells Roblox and Accolade Stock - Investing.com Nigeria
Cathie Wood's ARK ETF Buys CRISPR, Sells Roblox and Accolade Stock By Investing.com - Investing.com South Africa
Halper Sadeh LLC Investigates Accolade, Inc. Sale to Transcarent for Fairness to Shareholders - HPBL
Nisa Investment Advisors LLC Buys 55,314 Shares of Accolade, Inc. (NASDAQ:ACCD) - Defense World
Investigation into Accolade Transaction with Transcarent: Potential Breach of Fiduciary Duty – Market - HPBL
Accolade Inc. (ACCD): Q3 2025 Earnings Preview and Stock Outlook – Market - HPBL
Geode Capital Management Increases Stake in Accolade, Inc. – Market - HPBL
Accolade Sports Collection takes a swing at Switch today - GoNintendo
SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Accolade, Inc.ACCD - Victoria Advocate
Accolade (ACCD) Stock Update: Analyst Ratings and Market Performance – Market - HPBL
Review – Accolade Sports Collection - WayTooManyGames
Accolade shares soar on narrower quarterly loss, margin growth - MSN
Is Accolade, Inc. (ACCD) the Hottest Smid-Cap Stock So Far In 2025? - MSN
Cathie Wood's ARK sells Accolade stock, buys more Absci - MSN
0.42%
6.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):